Clinical Trial Update: Utilization of AMSC to Enhance Rotator Cuff Repair - Safety and Efficacy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of adipose-derived mesenchymal stem cells (AMSC) to enhance rotator cuff repair was terminated after evaluating safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotator Cuff Tear

Drugs mentioned

• AMSC (adipose-derived mesenchymal stem cells) (adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Bioinova, s.r.o. | Conditions: Rotator Cuff Tear | Phase 1, Phase 2 | Status: TERMINATED